Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins
Sign Up to like & getrecommendations! Published in 2018 at "Phlebology"
DOI: 10.1177/0268355516687864
Abstract: Scope Varithena® is a recently approved commercially available drug/delivery unit that produces foam using 1% polidocanol for the management of varicose veins. The purpose of this review is to examine the benefits of foam sclerotherapy,… read more here.
Keywords: endovenous microfoam; foam; management varicose; polidocanol endovenous ... See more keywords